MaxCyte, Inc. (MXCT)
NASDAQ · Healthcare
MaxCyte, Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- MaxCyte, Inc. total liabilities for the quarter ending December 31, 2025 were 31.0M, a 6.63% decrease year-over-year.
- MaxCyte, Inc. total liabilities for 2025 were 31.0M, a 6.63% decrease from 2024.
- MaxCyte, Inc. total liabilities for 2024 were 33.2M, a 8.00% decrease from 2023.
- MaxCyte, Inc. total liabilities for 2023 were 36.1M, a 10.47% increase from 2022.
- MaxCyte, Inc. total liabilities for 2022 were 32.7M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| MaxCyte, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $31 |
| 2024 | $33 |
| 2023 | $36 |
| 2022 | $33 |
| 2021 | $21 |
| 2020 | $19 |
| MaxCyte, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $31 |
| 2024-12-31 | $33 |
| 2023-12-31 | $36 |
| 2022-12-31 | $33 |
| 2021-12-31 | $21 |
| 2020-12-31 | $19 |
MaxCyte, Inc. Total Liabilities — FAQ
MaxCyte, Inc. (MXCT) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MXCT's total liabilities history?
The chart and table above show MaxCyte, Inc.'s total liabilities by year and by quarter, including the growth rate.